Additionally, the 36-month beta value for BRTX is 0.27. There are mixed opinions on the stock, with 1 analysts rating it as a “buy”, 1 rating it as “overweight”, 0 rating it as “hold”, and 0 rating it as “sell”.
The public float for BRTX is 6.89M and currently, short sellers hold a 1.92% ratio of that float. The average trading volume of BRTX on February 12, 2026 was 58.77K shares.
BRTX stock’s latest price update
BioRestorative Therapies Inc (NASDAQ: BRTX)’s stock price has dropped by -35.41% in relation to previous closing price of $0.64. Nevertheless, the company has seen a loss of -59.94% in its stock price over the last five trading days.
BRTX’s Market Performance
BioRestorative Therapies Inc (BRTX) has experienced a -59.94% fall in stock performance for the past week, with a -65.10% drop in the past month, and a -70.10% drop in the past quarter. The volatility ratio for the week is 24.65%, and the volatility levels for the past 30 days are at 10.04% for BRTX. The simple moving average for the past 20 days is -60.86% for BRTX’s stock, with a -71.63% simple moving average for the past 200 days.
BRTX Trading at -62.58% from the 50-Day Moving Average
After a stumble in the market that brought BRTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.50% of loss for the given period.
Volatility was left at 10.04%, however, over the last 30 days, the volatility rate increased by 24.65%.
Stock Fundamentals for BRTX
Current profitability levels for the company are sitting at:
- -37.85% for the present operating margin
- 0.8% for the gross margin
The net margin for BioRestorative Therapies Inc stands at -33.05%. The total capital return value is set at -6.58%. Equity return is now at value -207.73%, with -125.35% for asset returns.
Currently, EBITDA for the company is -$11.37 million with net debt to EBITDA at 0.05. When we switch over and look at the enterprise to sales, we see a ratio of 7.98. The receivables turnover for the company is 28.61for trailing twelve months and the total asset turnover is 0.07. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.37.
Conclusion
In conclusion, BioRestorative Therapies Inc (BRTX) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.